Skip to main content
. 2020 Jun 27;140:102008. doi: 10.1016/j.tre.2020.102008

Table 14.

Optimal capacity of PCs for producing whole-blood-derived platelets under each scenario.

3 4 5 6 7 8 3 4 5 6 7 8 3 4 5 6 7 8
S1 1 8 9 10 10 8 S2 2 5 6 5 5 4 4 S3 1 9 9 10 10 9
2 3 1 1 4 5 9 14 8 7 4 5 2 3
4 5 1 3 5 1 3 5 1 2
5 2 2
3 4 5 6 7 8 3 4 5 6 7 8 3 4 5 6 7 8
S4 1 6 10 10 11 10 8 S5 1 4 9 10 11 10 8 S6 4 1 9 10 14 11 10
2 3 1 1 2 3 1 1 5 1 3
5 2 2 4 4 4 6 2 4
3 4 5 6 7 8 3 4 5 6 7 8 3 4 5 6 7 8
S7 2 10 13 9 13 9 7 S8 2 6 7 5 5 4 4 S9 1 8 10 9 14 10 9
5 5 5 4 5 4 5 2 2 3
3 4 5 6 7 8 3 4 5 6 7 8 3 4 5 6 7 8
S10 1 6 10 9 14 10 9 S11 1 9 10 14 10 11 9 S12 5 5 5 4 5
4 2 4 1 1
3 4 5 6 7 8 3 4 5 6 7 8 3 4 5 6 7 8
S13 4 9 13 12 14 11 11 S14 2 9 14 8 14 9 8 S15 1 10 13 10 14 11 10